Peptide Stack · Research protocol
The CJC-1295 + Ipamorelin + Tesamorelin GH stack
The gold-standard GHRH + ghrelin mimetic stack for pulsatile growth hormone release — without exogenous HGH.
Protocol goal
Restore youthful pulsatile growth hormone release, improve body composition, sleep quality, and recovery — without shutting down endogenous production.
Protocol timeline
Adults 35+ noticing decline in recovery, sleep depth, and body composition. Athletes optimizing for durability.
Active malignancy. Retinopathy. Untreated sleep apnea. Type 2 diabetes with poor glycemic control.
Frequently asked questions
Why not just take HGH?
Exogenous HGH suppresses your natural production and can produce supraphysiologic IGF-1 (linked to insulin resistance and possibly cancer risk). GHRH + GHRP stacks amplify your natural pulsatile release, keeping the feedback loop intact.
What makes tesamorelin different from CJC-1295?
Both are GHRH analogs. Tesamorelin has FDA approval specifically for HIV-associated visceral adiposity — the strongest human evidence for visceral fat reduction. CJC-1295 has a longer half-life. Stacking gives you both signals.
Will this show up on drug tests?
Yes — WADA and USADA test for GHRH analogs and GHRPs. Not appropriate for tested athletes.